Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

NCT07391267 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases
MAFLD

Interventions

DRUG: Semaglutide Oral Tablet
OTHER: Placebo
OTHER: Standard medical treatment

Sponsor

Institute of Liver and Biliary Sciences, India